QUOTE AND NEWS
StreetInsider.com  Apr 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Senomyx%2C+Inc.+%28SNMX%29+Posts+Q1+Loss+of+7cShare/8277868.html for the full story.
StreetInsider.com  Mar 15  Comment 
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) 30.5% HIGHER; reported Q4 EPS of ($0.01), $0.30 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $8.87 million versus the consensus estimate of $1.16 million. Senomyx,...
StreetInsider.com  Mar 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Senomyx%2C+Inc.+%28SNMX%29+Misses+Q4+EPS+by+2c%3B+Issues+Weak+FY13+Outlook/8187759.html for the full story.
StreetInsider.com  Nov 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Senomyx%2C+Inc.+%28SNMX%29+Tops+Q3+EPS+by+1c/7856762.html for the full story.
Benzinga  Oct 9  Comment 
Senomyx (NASDAQ: SNMX), a company using proprietary taste science technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that the Company's four initial Savory Flavors and its...
StreetInsider.com  Aug 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Senomyx%2C+Inc.+%28SNMX%29+Misses+Q2+EPS+by+1c/7636542.html for the full story.
Benzinga  Jul 9  Comment 
Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste science technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that the Company's flavor modifiers for sucrose...
StreetInsider.com  May 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Senomyx%2C+Inc.+%28SNMX%29+Misses+Q1+EPS+by+3c%3B+Reaffirms/7398692.html for the full story.
Marketwire  May 3  Comment 
SAN DIEGO, CA -- (Marketwire) -- 05/03/12 -- Senomyx, Inc. (NASDAQ: SNMX) Recent Highlights Include: Firmenich exercises option to extend R&D funding for the Sweet Taste Program through July 2013 Marketing activities for Senomyx's S6973 Sucrose
Marketwire  May 1  Comment 
SAN DIEGO, CA -- (Marketwire) -- 05/01/12 -- Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste science technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced




 
TOP CONTRIBUTORS

Senomyx, Inc. was founded September 1998 by Howard Hughes Medical Investigators Charles Zuker and Roger Y. Tsien (Nobel Laureate), whom also founded Aurora Biosciences (acquired by Vertex Pharmaceuticals for about $592 million in stock). Senomyx uses taste receptor-based assays and screening technologies to discover and develop flavor enhancers and taste modulators for the food and beverage industry. The Company has entered into development collaborations with seven leading food, beverage, and ingredient supply companies, which include Ajinomoto Co., Inc., Cadbury Schweppes, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA and Solae LLC.

Senomyx’s current focus programs include the discovery and development of 1) savory, sweet, and salt flavor ingredients that can substitute or allow for the reduction of MSG, sugar, and salt in food and beverage products, 2) bitter blockers that will reduce or block bitter tastes in foods, beverages, and pharmaceuticals, and 3) cooling ingredients for a cooling taste effect for confectioneries, foods and beverages, and oral care and OTC healthcare products.

References

Xu, H., Staszewski, L., Tang, H., Adler, E., Zoller, M., and Li, X. (2004). Different functional roles of T1R subunits in the heteromeric taste receptors. Proc. Natl. Acad. Sci. USA, 101:14258-14263.

Li, X., Staszewski, L., Xu, H., Durick, K., Zoller, M., Adler, E. (2002). Human receptors for sweet and umami taste. Proc. Natl. Acad. Sci. U.S.A. 99, 4692-4696.

Ozeck, M., Brust, P., Xu, H., and Servant, G. (2004) Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways. Eur J Pharmacol. 489:139-149.

Pronin, A.N., Tang, H., Connor, J., and Keung, W. (2004). Identification of ligands for two human bitter T2R receptors. Chem Senses. 29:583-593.

Lu, M., Staszewski, L., Echeverri, F., Xu, H., and Moyer, B.D. (2004). Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression. BMC Cell Biol. 5:34-44

Lu, M., Echeverri, F., and Moyer, B.D. (2003) Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors. Traffic, 4:416-433.

Zozulya, S., Echeverri, F., Nguyen, T. (2001) The human olfactory receptor repertoire. Genome Biol. 2:RESEARCH0018.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki